Zhejiang Ausun Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 285.650 million compared to CNY 209.873 million a year ago. Operating income was CNY 92.408 million compared to CNY 57.779 million a year ago. Net income was CNY 82.685 million compared to CNY 52.598 million a year ago. Basic earnings per share from continuing operations was CNY 0.29 compared to CNY 0.2 a year ago.